Advertisement

Topics

Latest "Biomarker discovery Driving technologies" News Stories

09:15 EST 4th December 2016 | BioPortfolio

Here are the most relevant search results for "Biomarker discovery Driving technologies" found in our extensive news archives from over 250 global news sources.

More Information about Biomarker discovery Driving technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Biomarker discovery Driving technologies for you to read. Along with our medical data and news we also list Biomarker discovery Driving technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biomarker discovery Driving technologies Companies for you to search.

Showing "Biomarker discovery Driving technologies" News Articles 1–25 of 12,000+

Extremely Relevant

#news #biotech A new method simplifies blood biomarker discovery and analysis

// Scientists at Karolinska Institutet in collaboration with Estonian Competence Centre on Health Technologies have developed a new gene expression analysis method to widen the usage of blood in biomarker discovery and analysis. Their paper is published in the journal … Continue reading → Cet article #news #biotech A new method simplifies blood biomarker discovery and analysis est appa...


A new method simplifies blood biomarker discovery and analysis

Scientists at Karolinska Institutet in collaboration with Estonian Competence Centre on Health Technologies have developed a new gene expression analysis method to widen the usage of blood in biomarker discovery and analysis. Their paper is published in the journal Scientific Reports.

Scientists develop novel method to widen usage of blood in biomarker discovery and analysis

Scientists at Karolinska Institutet in collaboration with Estonian Competence Centre on Health Technologies have developed a new gene expression analysis method to widen the usage of blood in biomarker discovery and analysis. Their paper is published in the journal Scientific Reports.


University of Manchester and SCIEX open £18m Biomarker Discovery Centre

The Manchester, UK-based Stoller Biomarker Discovery Centre is a major step forward in precision medicine and making 'industrial' proteomics a reality

Relevant

Biomarkers technologies,markets and companies Prices from USD $5000

SummaryThis report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention. Tests based on biomarkers have been around for more than half a century, but interest in their application for diagnostics and drug discovery...

New method simplifies blood biomarker discovery and analysis

A new gene expression analysis method has been developed to widen the usage of blood in biomarker discovery and analysis, report scientists in a new article.

Stemina Biomarker Discovery, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.MarketLines' Stemina Biomarker Discovery, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, det...

Biomarker drug discovery company Blueprint Bio receives $7.5mm in Series A round

Blueprint Bio Inc. (personalized medicine using biomarker drug discovery) secured $7.5mm in its Series A financing round from Forentis Partners LLC. The company will use the proceeds to further develop its intellectual property and support additional drug discoveries.

Biomarker drug discovery company Blueprint Bio receives $7.5mm in early-stage funding

Blueprint Bio Inc. (personalized medicine using biomarker drug discovery) secured $7.5mm in early-stage funding from Forentis Partners LLC. The company will use the proceeds to further develop its intellectual property and support additional drug discoveries.

Celebration to Commemorate Ocean Ridge Biosciences’ Re-Opening at New Facility

FOR IMMEDIATE RELEASE Celebration to Commemorate Ocean Ridge Biosciences’ Re-Opening at New Facility Expanded and upgraded facility enables growth of South Florida life sciences-based company DEERFIELD BEACH, FL, October 25th, 2016 - Ocean Ridge Biosciences (ORB), a leader in RNA profiling and biomarker discovery services, will celebrate a grand re-opening at its new location, 394 SW 12th Aven...

C4X Discovery acquires more drug discovery technology from insolvent MolPlex

British company C4X Discovery has acquired a suite of advanced drug-discovery technologies from MolPlex…

Definiens Launches Clinical Development Offering to Provide Services from Discovery to ...

New Service Provides Comprehensive Solution for Tissue-Based Assay Development, Image Analysis and Biomarker Signature Discovery Read more...

#jobs #lifescience Immunocore: Bioinformatician- Biomarker discovery – Milton Park, Oxfordshire

// Competitive salary: Immunocore: Immunocore Limited, just south of Oxford, UK, is an innovative and dynamic biotechnology… Milton Park, Oxfordshire from Job Search RSS http://ift.tt/2eo9hRK Cet article #jobs #lifescience Immunocore: Bioinformatician- Biomarker discovery – Milton Park, Oxfordshire est apparu en premier sur Biotech 365.

Global Cancer Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 2022 Prices from USD $3900

The global cancer biomarkers market is anticipated to reach around $17 billion by 2022, with an estimated CAGR of 12.6% from 2016 to 2022. The market growth is driven by factors such as increasing prevalence of cancer, various technological developments in omics technologies; increased demand for personalized medicines especially in cancer therapies, rising number of clinical trials in developed a...

Oxford Global’s 3rd Annual Drug Discovery USA Congress – Final Agenda

Have you seen the final agenda for our 3rd Annual Drug Discovery USA Congress? Our expert panel of speakers will address the current strategies for directed discovery, including the resurgence of phenotypic screening and comparing its utility with target based discovery. They will explore novel peptide drug discovery, strategies for target selection and incorporating genomic technologies into dis...

Aelan licenses Buck Institute's AD biomarker IP

Aelan Cell Technologies licensed worldwide development and commercialization rights to Buck Institute for Research on Aging's intellectual property related to an epigenetic biomarker associated with human aging for potential use in Alzheimer's disease detection.

Evotec, Merck sign deals to partner on target discovery technologies

Evotec and Merck have signed agreements to collaborate on target discovery technologies.

Uber buys self-driving truck startup Otto; teams up with Volvo

Aug 18 (Reuters) - Ride service Uber Technologies Inc said on Thursday it has acquired the self-driving trucks startup Otto, and it also announced that Volvo Car Group has agreed to a $300 million alliance to develop self-driving cars.

UPDATE 1-Uber buys self-driving truck startup Otto; teams with Volvo

Aug 18 (Reuters) - Ride service Uber Technologies Inc said on Thursday it acquired self-driving trucks startup Otto and formed a $300 million alliance with Volvo Car Group to develop self-driving cars.

CORRECTED-UPDATE 1-Uber buys self-driving truck startup Otto; teams with Volvo

Aug 18 (Reuters) - Ride service Uber Technologies Inc said on Thursday it acquired self-driving trucks startup Otto and formed a $300 million alliance with Volvo Car Group to develop self-driving cars.

Parkinson's Disease Biomarker Found in Urinary Samples

A biomarker helps physicians predict, diagnose or monitor disease, because the biomarker corresponds to the presence or risk of disease,...

Evotec, Merck to collaborate on target discovery technologies

Evotec has announced the signing of a set of collaboration agreements with the life science business of Merck, which will combine Merck’s portfolio of genome editing technologies with Evotec’s versatile screening platforms and disease expertise. Evotec will leverage Merck’s comprehensive collection of genetic reagents such as viral CRISPR and shRNA libraries to enable new target ...

BRIEF-Evotec, Merck to collaborate on target discovery technologies

* Evotec and Merck enter into agreements to collaborate on target discovery technologies Source text for Eikon: Further company coverage:

Richard Buller, VP at Pfizer, to Give a Keynote at GTCbio’s Biomarker Summit Europe 2016

Berlin, Germany, July 10, 2016 --(PR.com)-- Richard E. Buller, Vice President of Oncology, Clinical Development & Head of Global Product Development at Pfizer will give a keynote presentation on, "Feedback Loops Between Biomarkers and Targeted Agents in Clinical Trials and Beyond: Lessons from Anaplastic Lymphoma Kinase (ALK+) Driven Non-Small Cell Lung Cancer (NSCLC)" at GTCbioR...

Global Central Nervous System CNS Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 2022 Prices from USD $3900

A biomarker is biological feature that can be used to measure the presence or progress of disease or the effects of treatment. For example, prostate specific antigen PSA is a biomarker for cancer of prostate. Biomarkers enable the researchers to quickly see large number of biological analytics. In the present scenario, the research and development in CNS market has paced up due to support from gov...


Quick Search
Advertisement
 

News Quicklinks